Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account / / Malik Osmane.
Saved in:
| VerfasserIn: | |
|---|---|
| Place / Publishing House: | Hamburg, Germany : : Anchor Academic Publishing,, 2014. 2014 |
| Year of Publication: | 2014 |
| Language: | English |
| Online Access: | |
| Physical Description: | 1 online resource (283 pages) :; illustrations (some color) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 01994nam a2200421 i 4500 | ||
|---|---|---|---|
| 001 | 5001640288 | ||
| 003 | MiAaPQ | ||
| 005 | 20200520144314.0 | ||
| 006 | m o d | | ||
| 007 | cr cnu|||||||| | ||
| 008 | 140416t20142014gw a ob 000 0 eng d | ||
| 020 | |z 9783954891870 | ||
| 020 | |z 9783954896875 (PDF) | ||
| 035 | |a (MiAaPQ)5001640288 | ||
| 035 | |a (Au-PeEL)EBL1640288 | ||
| 035 | |a (CaPaEBR)ebr10856569 | ||
| 035 | |a (OCoLC)871779662 | ||
| 040 | |a MiAaPQ |b eng |e rda |e pn |c MiAaPQ |d MiAaPQ | ||
| 050 | 4 | |a RS189 |b .O863 2014 | |
| 082 | 0 | |a 572 |2 23 | |
| 100 | 1 | |a Osmane, Malik, |e author. | |
| 245 | 1 | 0 | |a Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account / |c Malik Osmane. |
| 264 | 1 | |a Hamburg, Germany : |b Anchor Academic Publishing, |c 2014. | |
| 264 | 4 | |c 2014 | |
| 300 | |a 1 online resource (283 pages) : |b illustrations (some color) | ||
| 336 | |a text |2 rdacontent | ||
| 337 | |a computer |2 rdamedia | ||
| 338 | |a online resource |2 rdacarrier | ||
| 504 | |a Includes bibliographical references. | ||
| 588 | |a Description based on online resource; title from PDF cover (ebrary, viewed April 15, 2014). | ||
| 590 | |a Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
| 650 | 0 | |a Biological products. | |
| 650 | 0 | |a Drugs |x Generic substitution. | |
| 650 | 0 | |a Pharmaceutical biotechnology industry. | |
| 655 | 4 | |a Electronic books. | |
| 776 | 0 | 8 | |i Print version: |a Osmane, Malik. |t Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account. |d Hamburg, Germany : Anchor Academic Publishing, c2014 |h 12 pages |z 9783954891870 |
| 797 | 2 | |a ProQuest (Firm) | |
| 856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=1640288 |z Click to View |